期刊
NATURE BIOTECHNOLOGY
卷 28, 期 11, 页码 1157-1159出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt1110-1157
关键词
-
Efficiently generating evidence of clinical utility is a major challenge for ensuring clinical adoption of valuable diagnostics. A new approach to reimbursement in the United States offers a balance between evidence and incentives for molecular diagnostic tests.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据